Filing Details

Accession Number:
0001179110-11-004658
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-03-09 12:00:00
Reporting Period:
2011-03-07
Filing Date:
2011-03-09
Accepted Time:
2011-03-09 19:00:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1080014 Theravance Inc THRX Pharmaceutical Preparations (2834) 943265960
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1217420 D William Young Theravance, Inc.
901 Gateway Boulevard
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-07 10,752 $8.53 39,505 No 4 M Direct
Common Stock Disposition 2011-03-07 5,376 $22.31 34,129 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2011-03-07 10,752 $0.00 10,752 $8.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-04-07 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $22.09 to $22.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
  2. Immediately exercisable.